Stay updated on Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page.

Latest updates to the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedA new revision entry, v3.4.3, was added to the Record History, replacing the previous v3.4.2.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed older notices about government funding lapse and NIH operating status.SummaryDifference0.6%

- Check41 days agoChange DetectedNotice about government funding status added. Revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.6%

- Check48 days agoChange DetectedShow glossary option, color-coded highlights for changes (green for additions and red for deletions), and a new revision label (v3.4.0) are now displayed on the history page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check62 days agoChange DetectedFooter revision label updated from v3.3.3 to v3.3.4. No changes to study data or core page content.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter updates: added Revision: v3.3.3; HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Ixazomib Maintenance in Multiple Myeloma Clinical Trial page.